{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:55:13Z","timestamp":1788897313007,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["K23 DK084337"],"award-info":[{"award-number":["K23 DK084337"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AR055968"],"award-info":[{"award-number":["U01 AR055968"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linden Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00198-018-4787-z","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T11:15:49Z","timestamp":1543403749000},"page":"629-635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Disrupted radial and tibial microarchitecture in patients with monoclonal gammopathy of undetermined significance"],"prefix":"10.1007","volume":"30","author":[{"given":"E.M.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bucovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Shane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"issue":"1","key":"4787_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1359\/jbmr.0301212","volume":"19","author":"LJ Melton 3rd","year":"2004","unstructured":"Melton LJ 3rd, Rajkumar SV, Khosla S, Achenbach SJ, Oberg AL, Kyle RA (2004) Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 19(1):25\u201330. \n                    https:\/\/doi.org\/10.1359\/JBMR.0301212","journal-title":"J Bone Miner Res"},{"issue":"1","key":"4787_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","volume":"135","author":"H Gregersen","year":"2006","unstructured":"Gregersen H, Jensen P, Gislum M, Jorgensen B, Sorensen HT, Norgaard M (2006) Fracture risk in patients with monoclonal gammopathy of undetermined significance. Br J Haematol 135(1):62\u201367. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06269.x","journal-title":"Br J Haematol"},{"issue":"1","key":"4787_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00774-017-0817-8","volume":"36","author":"N Veronese","year":"2018","unstructured":"Veronese N, Luchini C, Solmi M, Sergi G, Manzato E, Stubbs B (2018) Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis. J Bone Miner Metab 36(1):128\u2013132. \n                    https:\/\/doi.org\/10.1007\/s00774-017-0817-8","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"4787_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1365-2141.2010.08207.x","volume":"150","author":"JR Berenson","year":"2010","unstructured":"Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (2010) Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 150(1):28\u201338. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08207.x","journal-title":"Br J Haematol"},{"issue":"11","key":"4787_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","volume":"87","author":"TM Therneau","year":"2012","unstructured":"Therneau TM, Kyle RA, Melton LJ 3rd, Larson DR, Benson JT, Colby CL, Dispenzieri A, Kumar S, Katzmann JA, Cerhan JR, Rajkumar SV (2012) Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc 87(11):1071\u20131079. \n                    https:\/\/doi.org\/10.1016\/j.mayocp.2012.06.014","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"4787_CR6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362\u20131369. \n                    https:\/\/doi.org\/10.1056\/NEJMoa054494","journal-title":"N Engl J Med"},{"issue":"2","key":"4787_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000162282","volume":"120","author":"T Golombick","year":"2008","unstructured":"Golombick T, Diamond T (2008) Prevalence of monoclonal gammopathy of undetermined significance\/myeloma in patients with acute osteoporotic vertebral fractures. Acta Haematol 120(2):87\u201390. \n                    https:\/\/doi.org\/10.1159\/000162282","journal-title":"Acta Haematol"},{"issue":"2","key":"4787_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jbspin.2009.12.002","volume":"77","author":"B Bouvard","year":"2010","unstructured":"Bouvard B, Royer M, Chappard D, Audran M, Hoppe E, Legrand E (2010) Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis. Joint Bone Spine 77(2):120\u2013124. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2009.12.002","journal-title":"Joint Bone Spine"},{"issue":"5","key":"4787_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2013-05-505776","volume":"123","author":"JN Farr","year":"2014","unstructured":"Farr JN, Zhang W, Kumar SK, Jacques RM, Ng AC, McCready LK, Rajkumar SV, Drake MT (2014) Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance. Blood 123(5):647\u2013649. \n                    https:\/\/doi.org\/10.1182\/blood-2013-05-505776","journal-title":"Blood"},{"issue":"25","key":"4787_CR10","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","volume":"118","author":"AC Ng","year":"2011","unstructured":"Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF, McCready LK, Melton LJ 3rd, Kyle RA, Rajkumar SV, Drake MT (2011) Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS. Blood 118(25):6529\u20136534. \n                    https:\/\/doi.org\/10.1182\/blood-2011-04-351437","journal-title":"Blood"},{"issue":"12","key":"4787_CR11","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/jbmr.152","volume":"25","author":"EM Stein","year":"2010","unstructured":"Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Zhang C, Yin PT, Cosman F, Nieves J, Guo XE, Shane E (2010) Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res 25(12):2572\u20132581. \n                    https:\/\/doi.org\/10.1002\/jbmr.152","journal-title":"J Bone Miner Res"},{"issue":"7","key":"4787_CR12","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1210\/jc.2011-0309","volume":"96","author":"EM Stein","year":"2011","unstructured":"Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Zhang C, Cosman F, Nieves J, Greisberg J, Guo XE, Shane E (2011) Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab 96(7):2041\u20132048. \n                    https:\/\/doi.org\/10.1210\/jc.2011-0309","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4787_CR13","doi-asserted-by":"publisher","first-page":"E1918","DOI":"10.1210\/jc.2012-1968","volume":"97","author":"EM Stein","year":"2012","unstructured":"Stein EM, Liu XS, Nickolas TL, Cohen A, McMahon DJ, Zhou B, Zhang C, Kamanda-Kosseh M, Cosman F, Nieves J, Guo XE, Shane E (2012) Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab 97(10):E1918\u2013E1926. \n                    https:\/\/doi.org\/10.1210\/jc.2012-1968","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4787_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jbmr.1841","volume":"28","author":"EM Stein","year":"2013","unstructured":"Stein EM, Silva BC, Boutroy S, Zhou B, Wang J, Udesky J, Zhang C, McMahon DJ, Romano M, Dworakowski E, Costa AG, Cusano N, Irani D, Cremers S, Shane E, Guo XE, Bilezikian JP (2013) Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res 28(5):1029\u20131040. \n                    https:\/\/doi.org\/10.1002\/jbmr.1841","journal-title":"J Bone Miner Res"},{"issue":"5","key":"4787_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/jbmr.2144","volume":"29","author":"EM Stein","year":"2014","unstructured":"Stein EM, Kepley A, Walker M, Nickolas TL, Nishiyama K, Zhou B, Liu XS, McMahon DJ, Zhang C, Boutroy S, Cosman F, Nieves J, Guo XE, Shane E (2014) Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning. J Bone Miner Res 29(5):1101\u20131109","journal-title":"J Bone Miner Res"},{"issue":"10","key":"4787_CR16","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00198-016-3621-8","volume":"27","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Rosete F, Zhang C, McMahon DJ, Guo XE, Shane E, Nishiyama KK (2016) In vivo assessment of bone structure and estimated bone strength by first- and second-generation HR-pQCT. Osteoporos Int 27(10):2955\u20132966. \n                    https:\/\/doi.org\/10.1007\/s00198-016-3621-8","journal-title":"Osteoporos Int"},{"issue":"12","key":"4787_CR17","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/jbmr.2387","volume":"29","author":"MT Drake","year":"2014","unstructured":"Drake MT (2014) Unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? J Bone Miner Res 29(12):2529\u20132533. \n                    https:\/\/doi.org\/10.1002\/jbmr.2387","journal-title":"J Bone Miner Res"},{"issue":"5","key":"4787_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1182\/blood-2013-11-539973","volume":"123","author":"E Terpos","year":"2014","unstructured":"Terpos E, Dimopoulos MA (2014) Less strength and more fractures for MGUS bones. Blood 123(5):603\u2013604. \n                    https:\/\/doi.org\/10.1182\/blood-2013-11-539973","journal-title":"Blood"},{"issue":"15","key":"4787_CR19","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","volume":"116","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Tang M, Pfeiffer RM, Bjorkholm M, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010) Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood 116(15):2651\u20132655. \n                    https:\/\/doi.org\/10.1182\/blood-2010-04-282848","journal-title":"Blood"},{"issue":"9","key":"4787_CR20","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1182\/blood.V90.9.3743","volume":"90","author":"M Pecherstorfer","year":"1997","unstructured":"Pecherstorfer M, Seibel MJ, Woitge HW, Horn E, Schuster J, Neuda J, Sagaster P, Kohn H, Bayer P, Thiebaud D, Ludwig H (1997) Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Blood 90(9):3743\u20133750","journal-title":"Blood"},{"issue":"6","key":"4787_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00223-008-9145-2","volume":"82","author":"J Pepe","year":"2008","unstructured":"Pepe J, Petrucci MT, Mascia ML, Piemonte S, Fassino V, Romagnoli E, Minisola S (2008) The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance. Calcif Tissue Int 82(6):418\u2013426. \n                    https:\/\/doi.org\/10.1007\/s00223-008-9145-2","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"4787_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1046\/j.1445-5994.2001.00055.x","volume":"31","author":"T Diamond","year":"2001","unstructured":"Diamond T, Levy S, Smith A, Day P, Manoharan A (2001) Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J 31(5):272\u2013278","journal-title":"Intern Med J"},{"issue":"5","key":"4787_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","volume":"134","author":"J Pepe","year":"2006","unstructured":"Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E, Minisola S (2006) Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 134(5):485\u2013490. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06217.x","journal-title":"Br J Haematol"},{"issue":"5","key":"4787_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","volume":"126","author":"M Politou","year":"2004","unstructured":"Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M, Layton M, Apperley JF, Dimopoulos MA, Rahemtulla A (2004) Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 126(5):686\u2013689. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05092.x","journal-title":"Br J Haematol"},{"issue":"9","key":"4787_CR25","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","volume":"101","author":"S Lentzsch","year":"2003","unstructured":"Lentzsch S, Gries M, Janz M, Bargou R, Dorken B, Mapara MY (2003) Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 101(9):3568\u20133573. \n                    https:\/\/doi.org\/10.1182\/blood-2002-08-2383","journal-title":"Blood"},{"issue":"5","key":"4787_CR26","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1172\/JCI80276","volume":"126","author":"J Fu","year":"2016","unstructured":"Fu J, Li S, Feng R, Ma H, Sabeh F, Roodman GD, Wang J, Robinson S, Guo XE, Lund T, Normolle D, Mapara MY, Weiss SJ, Lentzsch S (2016) Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease. J Clin Invest 126(5):1759\u20131772. \n                    https:\/\/doi.org\/10.1172\/JCI80276","journal-title":"J Clin Invest"},{"issue":"1","key":"4787_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1034\/j.1600-0609.2002.00505.x","volume":"69","author":"C Jakob","year":"2002","unstructured":"Jakob C, Zavrski I, Heider U, Brux B, Eucker J, Langelotz C, Sinha P, Possinger K, Sezer O (2002) Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. Eur J Haematol 69(1):37\u201342","journal-title":"Eur J Haematol"},{"issue":"1","key":"4787_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.critrevonc.2015.05.001","volume":"96","author":"V Pecoraro","year":"2015","unstructured":"Pecoraro V, Roli L, Germagnoli L, Banfi G (2015) The prognostic role of bone turnover markers in multiple myeloma patients: the impact of their assay. A systematic review and meta-analysis. Crit Rev Oncol Hematol 96(1):54\u201366. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2015.05.001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4787_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1365-2141.2000.01960.x","volume":"109","author":"R Fonseca","year":"2000","unstructured":"Fonseca R, Trendle MC, Leong T, Kyle RA, Oken MM, Kay NE, Van Ness B, Greipp PR (2000) Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients. Br J Haematol 109(1):24\u201329","journal-title":"Br J Haematol"},{"issue":"11","key":"4787_CR30","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1359\/jbmr.1999.14.11.1902","volume":"14","author":"Y Nishi","year":"1999","unstructured":"Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ, Gelb BD (1999) Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 14(11):1902\u20131908. \n                    https:\/\/doi.org\/10.1359\/jbmr.1999.14.11.1902","journal-title":"J Bone Miner Res"},{"key":"4787_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29\u201337. \n                    https:\/\/doi.org\/10.1016\/j.bone.2016.10.007","journal-title":"Bone"},{"issue":"4","key":"4787_CR32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3109\/10428194.2013.820288","volume":"55","author":"IB Kristensen","year":"2014","unstructured":"Kristensen IB, Christensen JH, Lyng MB, Moller MB, Pedersen L, Rasmussen LM, Ditzel HJ, Abildgaard N (2014) Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease. Leuk Lymphoma 55(4):911\u2013919. \n                    https:\/\/doi.org\/10.3109\/10428194.2013.820288","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"4787_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0609.2008.01164.x","volume":"82","author":"U Heider","year":"2009","unstructured":"Heider U, Kaiser M, Mieth M, Lamottke B, Rademacher J, Jakob C, Braendle E, Stover D, Sezer O (2009) Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment. Eur J Haematol 82(1):31\u201338. \n                    https:\/\/doi.org\/10.1111\/j.1600-0609.2008.01164.x","journal-title":"Eur J Haematol"},{"issue":"6","key":"4787_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","volume":"80","author":"M Kaiser","year":"2008","unstructured":"Kaiser M, Mieth M, Liebisch P, Oberlander R, Rademacher J, Jakob C, Kleeberg L, Fleissner C, Braendle E, Peters M, Stover D, Sezer O, Heider U (2008) Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma. Eur J Haematol 80(6):490\u2013494. \n                    https:\/\/doi.org\/10.1111\/j.1600-0609.2008.01065.x","journal-title":"Eur J Haematol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4787-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T19:34:57Z","timestamp":1574883297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4787-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4787"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4787-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]},"assertion":[{"value":"22 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Emily Stein, Alexander Dash, Sanchita Agarwal, Mariana Bucovsky, Jing Fu, Elizabeth Lentzsch, and Elizabeth Shane declare that they have no conflict of interest. Dr. Lentzsch is chief scientific advisor and shareholder of Caelum Biosciences and advisor for Janssen, Bayer, and Karyopharm.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}